Horton DM, Saint DA, Owens JA, Gatford KL, Kind KL. Use of the hyperinsulinemic euglycemic clamp to assess insulin sensitivity in guinea pigs: dose response, partitioned glucose metabolism, and species comparisons. Am J Physiol Regul Integr Comp Physiol 313: R19 -R28, 2017. First published April 24, 2017; doi:10.1152/ajpregu.00028.2017.-The guinea pig is an alternate small animal model for the study of metabolism, including insulin sensitivity. However, only one study to date has reported the use of the hyperinsulinemic euglycemic clamp in anesthetized animals in this species, and the dose response has not been reported. We therefore characterized the doseresponse curve for whole body glucose uptake using recombinant human insulin in the adult guinea pig. Interspecies comparisons with published data showed species differences in maximal whole body responses (guinea pig Ϸ human Ͻ rat Ͻ mouse) and the insulin concentrations at which half-maximal insulin responses occurred (guinea pig Ͼ human Ϸ rat Ͼ mouse). In subsequent studies, we used concomitant D-[3-3 H]glucose infusion to characterize insulin sensitivities of whole body glucose uptake, utilization, production, storage, and glycolysis in young adult guinea pigs at human insulin doses that produced approximately half-maximal (7.5 mU·min Ϫ1 ·kg Ϫ1 ) and near-maximal whole body responses (30 mU·min Ϫ1 ·kg Ϫ1 ). Although human insulin infusion increased rates of glucose utilization (up to 68%) and storage and, at high concentrations, increased rates of glycolysis in females, glucose production was only partially suppressed (~23%), even at high insulin doses. Fasting glucose, metabolic clearance of insulin, and rates of glucose utilization, storage, and production during insulin stimulation were higher in female than in male guinea pigs (P Ͻ 0.05), but insulin sensitivity of these and whole body glucose uptake did not differ between sexes. This study establishes a method for measuring partitioned glucose metabolism in chronically catheterized conscious guinea pigs, allowing studies of regulation of insulin sensitivity in this species. guinea pig; insulin sensitivity; sex differences; species differences INSULIN SECRETION and its actions on glucose metabolism in vivo have been characterized in a range of species, using chronically catheterized preparations to reduce the impact of the stress of anesthesia and surgery. The hyperinsulinemic euglycemic clamp (HEC, 8) is considered the reference standard method for measurement of insulin sensitivity (39). Concomitant administration of radiolabeled glucose during the HEC also allows the metabolic fate of glucose and insulin actions to be partitioned between central and peripheral actions. This approach has been used extensively in small mammalian species, such as the mouse and rat, to investigate the insulin axis under normal and pathophysiological conditions (1, 20, 29, 43, 52 ). An alternative animal model is the guinea pig, which resembles the human in its susceptibility to diabetes (32, 33) and dietinduced elevated circulating LDL cholesterol and atherosclerosis (12). However, to date, use of the HEC has only been reported in a single study in guinea pigs, investigating the effects of the chemotherapeutic agent cisplatin on insulin sensitivity (57). Only males were used in this study, and they were assessed at a single insulin dose and under general anesthesia (57), which reduces whole body and hepatic insulin sensitivity in the rat (5). Validation of the methodology for the HEC and characterization of both whole body and partitioned insulin action on glucose metabolism in conscious male and female guinea pigs are required to enable further study of insulin sensitivity and its regulation in this species.
for measurement of insulin sensitivity (39) . Concomitant administration of radiolabeled glucose during the HEC also allows the metabolic fate of glucose and insulin actions to be partitioned between central and peripheral actions. This approach has been used extensively in small mammalian species, such as the mouse and rat, to investigate the insulin axis under normal and pathophysiological conditions (1, 20, 29, 43, 52) . An alternative animal model is the guinea pig, which resembles the human in its susceptibility to diabetes (32, 33) and dietinduced elevated circulating LDL cholesterol and atherosclerosis (12) . However, to date, use of the HEC has only been reported in a single study in guinea pigs, investigating the effects of the chemotherapeutic agent cisplatin on insulin sensitivity (57) . Only males were used in this study, and they were assessed at a single insulin dose and under general anesthesia (57) , which reduces whole body and hepatic insulin sensitivity in the rat (5) . Validation of the methodology for the HEC and characterization of both whole body and partitioned insulin action on glucose metabolism in conscious male and female guinea pigs are required to enable further study of insulin sensitivity and its regulation in this species.
The sequence of insulin in hystricomorph mammals such as the guinea pig is relatively divergent from that of other mammals, sharing~65% homology across the entire sequence, whereas the sequence of the A and B regions of insulin is tightly conserved (90 -95%) in other mammals (61) . This difference in sequence translates to lower activity of guinea pig insulin compared with that of other species. For example, guinea pig insulin has only~10% of the potency of bovine insulin as a stimulus for glucose oxidation in rat tissues (64) and is~3% as potent as porcine, bovine, or recombinant human insulin in stimulating glucose oxidation in rat adipocytes (25) . In contrast, the insulin receptors of guinea pigs, humans, and rats share similar binding affinities for chicken and porcine insulin (37) , suggesting that responses to a single type of insulin may be similar across species. In vivo metabolic responses to human insulin have not been compared between guinea pig and other species, and whether the guinea pig responds sufficiently to human insulin to allow assessment of changes in insulin receptor number and downstream signaling has not been established.
Hence the aim of this study was to characterize the human insulin dose-response curve for whole body glucose metabolism in chronically catheterized guinea pigs using the HEC and compare that to dose responses to human insulin in other species. Second, we measured whole body glucose utilization, production, glycolysis, and storage and their responsiveness to human insulin in chronically catheterized young adult guinea pigs and compared these between males and females.
MATERIALS AND METHODS

Animals
All animal studies were approved by the Animal Ethics Committee of the University of Adelaide (approval no. M56/96). Adult male guinea pigs (n ϭ 8, 3-4 mo of age; Institute of Medical and Veterinary Science Tri-colored, Gilles Plains Resource Centre, Gilles Plains, SA, Australia) were used for the initial insulin dose-response study. Management of animals used for all additional experiments was as described previously (18) . Nulliparous female guinea pigs (3-4 mo of age) were entered into a mating program, and their progeny were studied as young adults at 100 days of age. All animals were housed under 12:12-h light-dark conditions and had ad libitum access to a commercial guinea pig/rabbit ration modified with an increased content of vitamin E (165 mg/kg), except when fasted for HEC studies as described below, and free access to tap water supplemented with ascorbic acid (400 mg/l).
Catheterization
A total of 84 guinea pigs underwent surgery for the insertion of vascular catheters. Body weight in the males ranged from 678 to 942 g (806 Ϯ 11 g, means Ϯ SE, n ϭ 45) and in the females from 562 to 806 g (686 Ϯ 10 g, n ϭ 39). Male and female animals were reproductively intact, and females were spontaneously cycling. Catheters were inserted into the right jugular vein (Silastic tubing, 0.51-mm ID, 0.94-mm OD, sleeved onto polyvinyl, 0.5-mm ID, 1.00-mm OD) and right carotid artery (polyvinyl tubing, 0.4-mm ID, 0.8-mm OD, sleeved into polyvinyl, 0.58-mm ID, 0.96-mm OD) under general anesthesia induced by ketamine (75 mg/kg body wt ip) and xylazine (6 mg/kg body wt im). Both carotid and jugular catheters were successfully implanted in 80 animals (95%). Catheters were maintained by flushing daily with heparinized saline (500 U/ml). Patent carotid and jugular catheters were present in 78, 68, 58, and 40% of the guinea pigs at 5, 7, 10, and 14 days after surgery, respectively. HEC studies commenced a minimum of 5 days after surgery and were successfully completed in 66 of the 80 catheterized guinea pigs.
Hyperinsulinemic Euglycemic Clamps
Guinea pigs were fasted for 16 h before each HEC, and HEC commenced at 0900. Extension lines, made from polyvinyl tubing, were attached to the catheters and exteriorized through the top of the cage allowing guinea pigs to remain unrestrained in their home cage during the experiment. Blood samples during the clamp were collected via the arterial catheter. Infusions of insulin and glucose were delivered via the jugular vein catheter.
Recombinant human insulin (Actrapid; Novo Nordisk, Bagsvaerd, Denmark) was diluted in 0.9% NaCl to the required concentration and infused intravenously at a rate of 25 l/min for 120 min. In a subset of eight males, the effect of increasing the rate of insulin infusion was examined by performing separate, sequential HEC at insulin infusion rates of 7.5 (n ϭ 8), 15 (n ϭ 8), 30 (n ϭ 3), and 60 (n ϭ 4) mU·min Ϫ1 ·kg Ϫ1 . At least 3 days of recovery were allowed between each HEC. In a separate cohort of animals, HEC were performed using insulin infusions of either 7.5 (n ϭ 31 male, n ϭ 22 female) or 30 mU·min Ϫ1 ·kg Ϫ1 (n ϭ 16 male, n ϭ 19 female). Twenty-five of these animals had HEC performed at both 7.5 and 30 mU·min Ϫ1 ·kg Ϫ1 insulin infusion rates. For these animals, doses were randomized, and at least 3 days of recovery were allowed between clamps. These included 19 animals in which partitioned glucose infusion was measured as described below.
Blood glucose was measured by glucometer (HemoCue, Ä ngelholm, Sweden) in fasting samples collected 20, 15, 10, 5, and 0 min before the start of the insulin infusion and in blood (50 -100 l) collected every 5 min throughout the HEC. Intravenous infusion of glucose (10% glucose; Baxter Healthcare, Sydney, NSW, Australia) commenced 15 min after the start of the insulin infusion. The glucose infusion rate (GIR) was adjusted on the basis of the blood glucose measurements to restore and maintain euglycemia, which was defined as the mean fasting blood glucose concentration. Glucose infusion rates were determined using a modified version (46) of the algorithm described by DeFronzo et al. (8) .
A subset (n ϭ Larger arterial blood samples (500 l) were collected at Ϫ20, Ϫ15, Ϫ10, Ϫ5, 0, 60, 75, 80, 85, 90, 95, 105, and 120 min from the start of the insulin infusion for subsequent analysis of radiolabeled metabolites and human and guinea pig insulin. Blood was centrifuged at 3,000 rpm for 15 min, and plasma was removed and stored at Ϫ20°C. The total blood volume removed from each guinea pig during the experiment was~7.5 ml (~12% of blood volume in a young adult guinea pig). The average fluid volume infused throughout the 2 h of the clamp was 9 ml in the 7.5 mU·min Ϫ1 ·kg Ϫ1 clamps and 11.5 ml for the 30 mU·min Ϫ1 ·kg Ϫ1 clamps.
Comparative Whole Body Insulin Sensitivity of Glucose Metabolism
To identify studies in which the whole body insulin sensitivity of glucose metabolism had been assessed, PubMed was searched {"dose response" [ October 16, 2016 [("dose response" OR "dose curve") AND insulin AND glucose AND ("hyperinsulinemic euglycemic clamp" OR "hyperinsulinaemic euglycaemic clamp")], identified 30 sources, including duplicates. Abstract screening from both searches was used to identify 139 papers that potentially described in vivo evaluation of insulin sensitivity using 2 or more doses of insulin, and that were written in English. An additional 18 sources were identified for full-text screening from reference lists of these papers. Subsequent full-text screening restricted papers to those that described in vivo whole body net glucose uptake (glucose infusion rate) on a body weight basis in response to at least two doses of recombinant human insulin assessed by hyperglycemic euglycemic clamp in conscious, fasted, healthy adolescent or adult animals and excluding states of perturbed or manipulated insulin sensitivity such as pregnancy, lactation, obesity, and pharmacological treatments. Data for circulating insulin concentrations and net glucose uptake (glucose infusion rate) in the fasted (basal) state and at each insulin infusion rate were extracted and used to plot insulin dose responses for each study. Study characteristics of the 24 papers that met these criteria are summarized in Supplemental Material, Supplemental 
Analysis of Human and Guinea Pig Insulin
Human insulin concentrations were analyzed using a commercially available kit (Insulin-CT; CIS Bio International, Codolet, France). Cross-reactivity of guinea pig insulin in this assay was Ͻ2%. Guinea pig insulin concentrations were measured by radioimmunoassay (14, 23) , in plasma samples collected before (Ϫ10, Ϫ5, and 0 min) and at 60, 75, 90, 105, and 120 min of insulin infusion during the doseresponse studies. Guinea pig insulin was iodinated with Na 125 I (Amersham Pharmacia-Biotech, Sydney, NSW, Australia) and chloramine-T to specific activities of 35-50 Ci/g and separated from reaction components by chromatography on Sephadex G50 (Amersham Pharmacia-Biotech). Guinea pig insulin was measured in duplicate samples of guinea pig plasma and standards (0.1225-31.25 ng/ml). The amount of guinea pig insulin that inhibited radioligand binding by 50% averaged 485 pg, while the coefficient of variation for the same sample assayed on different occasions was 9.6% within assays and 5.3% between assays.
Plasma D-[3-3 H]glucose and 3 H2O for Partitioned Glucose Metabolism
The specific activities of D- [3- 3 H]glucose and of 3 H2O were measured in plasma samples collected before and during the HEC (Ϫ20, Ϫ15, Ϫ10, Ϫ5, 0, 60, 75, 80, 85, 90, 95, 105, and 120 min), using methods based on previous studies in the rat (26, 27) . Samples were deproteinized using 0.3 N Ba(OH) 2 
Calculations
Basal glucose concentrations were calculated by averaging values in samples collected Ϫ20, Ϫ15, Ϫ10, Ϫ5, and 0 min before commencing the insulin infusion. Steady-state plasma concentrations of guinea pig and human insulin were calculated as the average of concentrations measured every 15 min throughout the final hour of the HEC (60 -120 min). Steady-state glucose infusion rate (ssGIR) was calculated as the average GIR during the final hour of the clamp. Whole body insulin sensitivity was calculated by dividing ssGIR by steady-state plasma concentrations of human insulin. The posthepatic metabolic clearance rate (MCR) of human insulin was calculated as the insulin infusion rate during the HEC divided by steady-state plasma concentrations of human insulin.
Glucose utilization. A steady-state plateau of plasma D-[3-3 H]glucose specific activity was achieved during the last 20 -40 min of D- [3- tion. In the insulin-stimulated state, the rate of whole body glucose utilization equals the rate of endogenous glucose production plus the exogenous glucose infusion. Therefore endogenous glucose production was calculated as the rate of whole body glucose utilization minus exogenous glucose infusion (26, 27) .
Glycolysis and glucose storage. The 3 H in the C-3 position of
3 H]glucose is lost selectively to H2O during glycolysis (50) . Rates of whole body glycolysis were determined from the rate of increase in 3 H2O multiplied by the total body water mass and divided by the D- [3- 3 H]glucose specific activity. Plasma H2O was assumed to be 93% of plasma volume, and the mass of H2O in the body was assumed to be 65% of total body weight, based on estimates in rodents (26, 27) . The rate of whole body glycolysis was determined during the last 15 min of D- [3- 3 H]glucose infusion in the basal state and the last 60 min of insulin infusion. Glucose storage in each state was calculated as the difference between total glucose utilization and glycolysis.
Statistical Analysis
Data were analyzed using SPSS 24.0 for Windows (IBM, Armonk, NY) with the individual guinea pig as the unit of analysis. Because of inclusion of different animals in studies at each insulin dose, the effect of sex was determined by analysis of variance separately at each dose. The effects of recombinant human insulin infusion on plasma guinea pig insulin concentrations and on components of glucose metabolism were determined using paired two-tailed t-tests. Significance was accepted at P Ͻ 0.05, and results are expressed as means Ϯ SE.
RESULTS
Insulin Dose Response of Whole Body Glucose Metabolism
Blood glucose levels during the steady-state period of insulin infusion were similar to fasting blood glucose levels at all doses of insulin studied ( Table 1 ). The coefficient of variation of blood glucose during the 60 -120-min period of the clamp ranged from 6.5 to 10.5% at differing insulin doses (Table 1) . Circulating human insulin concentration and steady-state glucose infusion rate increased with increasing infusion rate of human insulin up to doses of 30 mU·min Ϫ1 ·kg Ϫ1 (Table 1 
Comparative Whole Body Insulin Sensitivity of Glucose Metabolism
Dose-response data for the net glucose uptake in response to human insulin were available for male or mixed-sex populations, in human (2-4, 6, 15, 16, 31, 34, 36, 40, 41, 44, 45, 51, 56, 58) , rat (13, 17, 47, 48, 55) , mouse (1, 52) , and pig (62) . Data in other species were only available for states of physiological challenge such as pregnancy or lactation, which were not included in the comparative analysis. Both the maximal glucose uptake rates and the concentrations of circulating insulin at which maximal uptake was evident differed between studies ( Fig. 2A) . In humans, dose responses were similar across multiple studies in male and mixed-sex adult popula-tions ( Fig. 2A) . To allow between-species comparisons, doseresponse curves were fitted to data from papers describing responses in intact adult male mice (1, 52), Wistar rats (13, 47, 48, 55) , and humans (2, 6, 15, 31, 44) , and the dose-response for guinea pig from the present study was added. Maximal rates of net glucose uptake, measured as glucose infusion rate required to maintain euglycemia, in guinea pigs (~85 mol·kg Ϫ1 ·min Ϫ1 ) were similar to those in humans (~80 mol·kg Ϫ1 ·min Ϫ1 ) but occurred at far higher circulating insulin concentrations (~14,000 U/ml compared with~1,000 U/ml, Fig. 2B ). On a per body weight basis, rates of maximal whole body glucose uptake responses to insulin were~160% higher in rats than in guinea pigs, and maximal responses were more than double in mice compared with rats (Fig. 2B) . The concentration of insulin at which half-maximal glucose uptake responses occurred was~150% higher in guinea pigs (~185 U/ml) compared with humans or rats (~71 and~73 U/ml, respectively, Fig. 2B ) and~200% higher compared with mice (~61 U/ml).
Whole Body Insulin Sensitivity and Partitioned Glucose Metabolism at Approximately Half-Maximal Insulin Dose (7.5 mU·min
In the cohort of guinea pigs in which whole body insulin sensitivity was assessed at 7.5 mU·min Ϫ1 ·kg Ϫ1 , fasting glucose was higher in females than in males (P Ͻ 0.05, Table 2 ). The coefficient of variation of blood glucose averaged 5.9% between 60 and 120 min of insulin infusion. Steady-state human insulin concentrations achieved during insulin infusion at 7.5 mU·min Ϫ1 ·kg Ϫ1 averaged 238 Ϯ 13 U/ml overall and were higher in males than in females (P Ͻ 0.007, Table 2 ), and the metabolic clearance rate of human insulin was higher in females than in males (P Ͻ 0.02, Table 2 ). Steady-state glucose infusion rates averaged 47.8 Ϯ 2.5 mol·min Ϫ1 ·kg Ϫ1 during the HEC, and ssGIR and whole body insulin sensitivity did not differ between males and females (Table 2) .
Similarly, in the cohort of guinea pigs in which partitioned glucose metabolism was measured during clamps at 7.5 mU·min Ϫ1 ·kg Ϫ1 insulin, fasting blood glucose was higher in females than in males (P Ͻ 0.001, Table 2 ), and steady-state human insulin concentrations and ssGIR did not differ between sexes (Table 2) . Basal rates of glucose production and utilization tended to be higher in females compared with males before the 7.5 mU·min Ϫ1 ·kg Ϫ1 HEC (P Ͻ 0.075 for both). Insulin infusion at 7.5 mU·min Ϫ1 ·kg Ϫ1 suppressed endogenous glucose production (P Ͻ 0.001, Table 2 ) and enhanced whole body glucose utilization in both males and females (P Ͻ 0.001, Table 2 ). The insulin-stimulated rates of glucose utilization at half-maximal insulin dose were higher in females than in males (P Ͻ 0.03, Table 2 ), and endogenous glucose production under insulin-stimulated conditions tended to be higher in females than in males (P ϭ 0.08, Table 2 ). Basal levels of whole body glycolysis and glucose storage did not differ between sexes before the HEC. Insulin infusion at 7.5 mU·min Ϫ1 ·kg Ϫ1 tended to enhance the rate of whole body glycolysis in males (P Ͻ 0.08), but not females (Table 2) . Whole body glucose storage was increased by insulin infusion in males (P Ͻ 0.001) and females (P Ͻ 0.005), and insulin-stimulated rates of glucose storage were higher in females than in males (P Ͻ 0.05, Table  2 ). Overall, glycolysis accounted for 43 Ϯ 6% (males, 50 Ϯ In the cohort of guinea pigs in which whole body insulin sensitivity was assessed at 30 mU·min Ϫ1 ·kg Ϫ1 (n ϭ 38), fasting glucose was higher in females than in males (P Ͻ 0.05, Table 3 ). The coefficient of variation of blood glucose averaged 6.7% during 60 -120 min of insulin infusion. Steady-state human insulin concentrations achieved during insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 averaged 3,199 Ϯ 156 U/ml overall and were higher in males than in females (P Ͻ 0.01, Table 3); however, metabolic clearance rate of human insulin did not differ between sexes. Steady-state glucose infusion rates averaged 65.4 Ϯ 3.0 mol·min -1 ·kg Ϫ1 during this HEC, and ssGIR and whole body insulin sensitivity did not differ between males and females (Table 3) .
In the guinea pigs in which partitioned glucose metabolism was measured at 30 mU·min Ϫ1 ·kg Ϫ1 (n ϭ 19), fasting blood glucose was also higher in females than in males (P Ͻ 0.05), and steady-state human insulin concentrations and glucose infusion rates did not differ between sexes (Table 3) . Insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 suppressed endogenous glucose production in males (P Ͻ 0.001) and females (P Ͻ 0.05) and enhanced whole body glucose utilization to a similar degree in both sexes (P Ͻ 0.001 for both, Table 3 ). Glucose production during insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 was higher in females than in males (P Ͻ 0.04), but the insulin-stimulated decrease in endogenous glucose production did not differ between the sexes. Insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 did not alter whole body glycolysis in males, but enhanced glycolysis in females (P Ͻ 0.01, Table 3 ), and therefore the insulinstimulated change in glycolysis from basal levels was higher in Fig. 2 . Whole body sensitivity of glucose metabolism to human insulin in conscious animals. A: data from individual studies. Data points from the same study are joined. B: dose-response curves fitted by three-parameter logistic regression to combined data for intact male mice, Wistar rats, humans, and guinea pigs. Symbol fills indicate sex (black, males; gray, mixed/not specified), and symbol shapes indicate species (circles, human; upward triangles, rat; downward triangles, mouse; squares, pig; diamonds, guinea pig). females than in males (P Ͻ 0.04, Table 3 ). Insulin-stimulated rates of glycolysis during the clamp also tended to be higher in females than in males (P Ͻ 0.06, Table 3 ). Prior to the 30 mU·min Ϫ1 ·kg Ϫ1 HEC, basal rates of glucose storage were higher in females than in males (P Ͻ 0.05). Insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 increased whole body glucose storage in males (P Ͻ 0.001) and females (P Ͻ 0.04), and insulinstimulated glucose storage was similar in males and females (Table 3 ). In the fasting state, before insulin infusion at 30 mU·min Ϫ1 ·kg Ϫ1 , glycolysis accounted for 43 Ϯ 6% of glucose utilization, and glucose storage accounted for 57 Ϯ 6%. Glycolysis accounted for a higher percentage of glucose utilization in males than in females (males, 54 Ϯ 9%; females, 31 Ϯ 6%; P Ͻ 0.04), and conversely, glucose storage accounted for a lower percentage of utilization in males (males, 46 Ϯ 9%; females, 69 Ϯ 6%; P Ͻ 0.04). In the insulin-infused state, at 30 mU·min Ϫ1 ·kg Ϫ1 insulin, glycolysis accounted for 38 Ϯ 3% of glucose utilization (males, 36 Ϯ 4%; females, 40 Ϯ 5%), glucose storage accounted for 62 Ϯ 3% (males, 64 Ϯ 4%; females, 60 Ϯ 5%), and there were no differences between males and females.
DISCUSSION
This study has characterized whole body glucose metabolism and its response to insulin in the euglycemic state in the chronically catheterized guinea pig and includes the first doseresponse study for insulin action in this species. Although maximal whole body glucose uptake responses to insulin on a per body weight basis in guinea pigs were similar to those in humans, adult male guinea pigs were less insulin sensitive than humans, rats, or mice. Human insulin increased glucose utilization and suppressed endogenous glucose production in the guinea pig, and the insulin sensitivity for suppression of endogenous glucose production was also lower in the guinea pig than reported previously in human (7, 30, 31, 49 ) or in other small experimental species, such as rats and mice (1, 26, 27, 52, 54) . Nevertheless, these studies have demonstrated that HEC using human insulin can be used for quantitative assessment of insulin sensitivity in the guinea pig. As the guinea pig resembles the human in its susceptibility to diabetes (32, 33) and atherosclerosis and in aspects of cholesterol homeostasis (12) , this establishes methodology that will allow this species to be used for further investigation of the mechanistic basis underlying perturbations of glucose metabolism and insulin action.
Although the HEC is well established and used in rats and mice (1, 26, 27, 29, 52) , the volume of blood that can be sampled and the number of experiments and analyses possible is limited in these species, particularly in younger animals. The guinea pig, in contrast, ranges in weight from 60 to 140 g at birth and attains a body weight of 400 g by 3-4 wk of age, thus avoiding some of the limitations related to size and body weight in other small animal models. This greater size and the ability to maintain catheters in this species also permitted repeat HEC studies to be performed in the chronically catheterized young adult guinea pig in the present study. An additional potential advantage of the guinea pig is the ability to differentiate infused and endogenous insulin and directly measure suppression of insulin secretion. Infusion of human insulin suppressed circulating guinea pig insulin in the present study, providing direct evidence that human insulin does not crossreact in this guinea pig insulin assay.
When compared with insulins of other species, guinea pig insulin has a very low affinity for many mammalian insulin receptors, including its own (37), reflecting the low homology of guinea pig insulin with those of most other mammals (61) . Bolus doses of guinea pig insulin are only approximately one-third as potent as bovine insulin in lowering blood glucose in the guinea pig (64) . The guinea pig appears to compensate for this through an increased plasma insulin concentration and ). Glucose infusion rate, plasma human insulin, whole body insulin sensitivity, and metabolic clearance rates (MCR) are averaged during steady-state conditions from 60 to 120 min of insulin infusion. For whole body insulin sensitivity, human insulin concentrations were available for n ϭ 13 males and 18 females. For partitioned glucose metabolism, human insulin concentrations were available for n ϭ 6 males and 5 females; N/A, not applicable.
a P Ͻ 0.10, b P Ͻ 0.05, c P Ͻ 0.01, d P Ͻ 0.001 compared with value for males. e P Ͻ 0.05, f P Ͻ 0.01, g P Ͻ 0.001 compared with basal level before the clamp within each sex.
possibly an increased tissue abundance of insulin receptors (14, 23, 37, 64) . Although the sequence of insulin has diverged between species, the receptor for insulin is functionally conserved and binds chicken and porcine insulins in vitro with affinity similar to that of receptors from humans and rats (37) . This study reports the first in vivo dose-response study for insulin in the guinea pig and establishes insulin infusion rates and concentrations at which approximately half-maximal and maximal whole body glucose uptake responses are obtained. Our results were somewhat inconsistent with those reported in a previous study utilizing the HEC in male guinea pigs. In that study, infusion of human insulin at 3 mU/kg generated a plateau plasma insulin concentration of 100 Ϯ 5 U/ml in their control groups, and glucose infusion rates of~72-83 mol·min Ϫ1 ·kg Ϫ1 were required to maintain euglycemia (57) . These ssGIR resemble the rates of 65.4 mol·min Ϫ1 ·kg Ϫ1 required to maintain glycemia at human insulin concentrations of~3,200 U/ml in the current study. A number of factors may have contributed to the discrepancies in apparent insulin sensitivity between these two studies. Guinea pigs were anesthetized during the HEC in the previous study (57) ; however, in rats, anesthesia reduces insulin sensitivity (5), suggesting that anesthesia may not explain the differences. In addition, the body weight of animals studied by Szilvássy et al. (57) ranged from 350 to 400 g, a considerably lighter weight than the male guinea pigs in the current study, and animals were fasted for 24 h compared with 16 h used in this study. In mice, fasting time can influence insulin sensitivity assessed by HEC, with insulin sensitivity increasing following an 18-h compared with a 5-h fast (1) . Furthermore, details of the assay used to measure plasma insulin in the previous study were not provided (57) . Hence, although the previous study (57) reported a higher ssGIR at a lower steady-state insulin concentration in the guinea pig than we observed, differences in experimental design may explain this. On the basis of the dose-response study we performed in adult male guinea pigs, the sensitivity of whole body glucose metabolism to human insulin is lower in guinea pig than in adult male human (2, 6, 15, 31, 44) , Wistar rat (13, 47, 48, 55) , and mouse (1, 52) , despite similar receptor binding of mammalian insulin previously reported in vitro (37) . Maximal rates of net glucose uptake in guinea pigs were similar to those of humans but less than half of those evident in rats and Ͻ25% of rates of glucose uptake in mouse when expressed on a body weight basis, whereas half-maximal glucose uptake was achieved at insulin concentrations~150% higher in guinea pigs than in humans or rats. Similar to species differences in the insulin sensitivity of whole body glucose uptake, tissue-specific glucose metabolism and its regulation by insulin differed between humans and guinea pigs as well as compared with rodents. In the guinea pig, as in other species, glucose is utilized predominantly for oxidative purposes and carbon dioxide production, with much of the remainder directed to hepatic glycogen storage in the fasted state or to lipid storage in adipose tissue in the fed state (38) . In the present study, fasting (basal) rates of endogenous glucose production in the guinea pig were high (e.g., 61 shown that hepatic insulin sensitivity also differs in this species from many others and is less insulin responsive than glucose utilization in the guinea pig. In the present study, human insulin infusion at 7.5 mU·min Ϫ1 ·kg Ϫ1 suppressed endogenous glucose production by 20% and stimulated glucose utilization by 39% in the guinea pig, whereas infusion of human insulin at 30 mU·min Ϫ1 ·kg Ϫ1 suppressed glucose production by an average of 23% and increased glucose utilization by 68%. In contrast, in humans, maximal suppression of endogenous production is achieved at lower insulin concentrations than those required to stimulate maximal rates of glucose utilization. For example, in dose-response studies using porcine insulin (49), half-maximal suppression of endogenous glucose production occurred at insulin concentrations of 29 Ϯ 2 U/ml, whereas half-maximal stimulation of glucose utilization occurred at 55 Ϯ 7 U/ml. Similar results are reported in the rat and mouse, with lower plasma insulin concentrations required to achieve maximal suppression of endogenous glucose production compared with those required for stimulation of glucose utilization (1, 26, 54) . In rats, endogenous glucose production is suppressed by Ͼ90%, and glucose uptake is stimulated 5-fold at insulin concentrations of 124 U/ml during HEC with porcine insulin (54) . Endogenous glucose production is completely suppressed by elevated insulin concentrations (37 U/ml), and glucose uptake is increased by more than fivefold at higher insulin concentrations (183 U/ml) during HEC with human insulin in mouse (1) . Similarly, in humans, maximal and complete suppression of glucose production occurs at an insulin concentration of 57 U/ml, and an approximately fivefold increase in glucose utilization occurs at plateau plasma insulin levels of 678 U/ml (49). In the guinea pig, a 37% suppression of endogenous glucose production and 68% increase in glucose utilization during the 30 mU·min Ϫ1 ·kg
Ϫ1
HEC were observed at human insulin concentrations of Ͼ3,000 U/ml, suggestive of lower activity of human insulin in guinea pig liver and peripheral tissues compared with its actions in human tissues. This study provides the first evidence of sex differences in glucose metabolism in the young adult guinea pig. Compared with males, female guinea pigs had higher fasting glucose, metabolic clearance of insulin, and rates of glucose utilization, storage, and production during insulin stimulation. Whole body insulin sensitivity and the insulin sensitivity of endogenous glucose production and glucose utilization did not differ between the sexes, although the insulin-stimulated increase in glycolysis was greater in females than in males at high-dose insulin. Metabolic clearance of insulin is greater in women than in men (21) , similar to the sex differences that we observed in guinea pigs. Whole body insulin sensitivity of glucose metabolism is generally higher in women than in men, as in female compared with male rodents [reviewed by Magkos et al. (35) and Varlamov et al. (59) ], although in some studies, greater whole body insulin sensitivity in women is only seen when expressed per unit muscle mass, rather than per unit body weight (63) . This greater whole body insulin sensitivity of glucose uptake in women is partly due to greater insulin sensitivity of skeletal muscle, which was 47% higher for femoral muscle in women than in men when directly measured using labeled glucose and positron emission tomography (42) . We have reported that relative weights of fat depots and muscles are similar in male and female guinea pigs at ages similar to those in the present study (18) , suggesting that sex differences in insulin sensitivity are unlikely to reflect sex differences in body composition in these young adult guinea pigs. Greater rates of glucose utilization and storage in female than in male guinea pigs therefore imply that in guinea pigs, as in humans, the insulin sensitivity of peripheral tissue is higher in females than in males. The direction of sex differences in hepatic insulin sensitivity in humans is also consistent with those for whole body responses. In the basal (fasting) state, sex differences vary between studies, with either similar or~20% higher rates of endogenous glucose production in women than in men [reviewed by Magkos et al. (35) and Varlamov et al. (59) ]. Our finding of greater basal endogenous glucose production in female than in male guinea pigs (29 and 25% sex difference before 7.5 and 30.0 mU·min Ϫ1 ·kg Ϫ1 dose insulin clamps, respectively) is thus not inconsistent with reports in humans. In young adult guinea pigs, endogenous glucose production remained higher in females than in males at insulin doses producing approximately half-maximal and near-maximal increases in net glucose uptake, and the decrease from basal rates did not differ between sexes at either dose. This contrasts with humans, where suppression of endogenous glucose production is greater in women than in men at low, but not at high, doses of insulin [reviewed by Magkos et al. (35) ]. Differences in relative adiposity and lean muscle mass and the potential actions of steroid hormones are suggested as potential factors contributing to sex-specific differences in insulin sensitivity and glucose metabolism, including risk of type 2 diabetes, which is usually diagnosed at younger ages and lower body mass index in men than in women (22, 35, 59, 63) . Our finding of sex differences in insulin regulation of glucose metabolism in the guinea pig reinforces the need to include animals of both sexes in studies investigating perturbations of insulin sensitivity of glucose metabolism in the guinea pig.
Perspectives and Significance
This study has validated the HEC in chronically catheterized male and female guinea pigs and has confirmed that concomitant tracer infusions can also be utilized to investigate partitioned glucose metabolism in the unanesthetized guinea pig. Human insulin stimulated glucose utilization and suppressed endogenous glucose production in the guinea pig, although the relative magnitude of these changes differed from those reported during HEC in the human, rat, and mouse. This species is likely to be a useful additional small animal model for biomedical research, in part because of its relatively large size enabling studies early in life and the similarities between guinea pig and human cholesterol metabolism. The smaller litter size of guinea pigs compared with rats, often used to investigate effects of perturbations during pregnancy and lactation (9, 10, 53, 60) , and the precocial developmental patterns in guinea pigs similar to those of humans, including presence of~10% body fat at term birth (11) , are likely to make this species particularly valuable for studies of developmental programming. We have already reported that restricted fetal growth due to maternal feed restriction or large litter size in guinea pigs programs postnatal appetite, growth, and adiposity (18) and perturbs cholesterol metabolism and glucose tolerance (23, 24) , and establishment of methods for HEC in guinea pigs will enable future studies of programming of glucose metabolism by perinatal exposures in this species. Finally, a unique feature of guinea pigs is the ability to differentiate endogenous guinea pig insulin from infused (heterologous) insulin (the reason why antibodies used to detect insulin from other species are largely raised in guinea pig), enabling investigation of insulin suppression of its own secretion in this species.
